SEARCH

SEARCH BY CITATION

References

  • 1
    Bonilla FA, Bernstein IL, Khan DA et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 2005; 94 (5 Suppl. 1):S163.
  • 2
    Grumach AS, Duarte AJ, Bellinatti-Pires R et al. Brazilian report on primary immunodeficiencies in children: 166 cases studied over a follow-up time of 15 years. J Clin Immunol 1997; 17:2405.
  • 3
    Leiva LE, Zelazco M, Oleastro M et al. for the Latin American Group for Primary Immunodeficiency Diseases. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol 2007; 27:1018.
  • 4
    Hawlisch H, Kohl J. Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol Immunol 2006; 43:1321.
  • 5
    Lutz HU, Jelezarova E. Complement amplification revisited. Mol Immunol 2006; 43:212.
  • 6
    Sjoholm AG, Jonsson G, Braconier JH et al. Complement deficiency and disease: an update. Mol Immunol 2006; 43:7885.
  • 7
    Blanchong C, Zhou B, Rupert KL et al. Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (CCX) modules in Caucasians: the load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med 2000; 191:218396.
  • 8
    Yu CY. The complete exon–intron structure of a human complement C4A gene. J Immunol 1991; 146:105766.
  • 9
    Chung EK, Yang Y, Rupert KL et al. Determining the one, two, three, or four and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins. Am J Hum Genet 2002; 71:81022.
  • 10
    Yang Y, Chung EK, Zhou B et al. Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities and body mass index. J Immunol 2003; 171:273445.
  • 11
    Yang Z, Yu CY. Organizations and gene duplications of the human and mouse MHC complement gene clusters. Exp Clin Immunogenet 2000; 17:117.
  • 12
    Clayton PE, Miller WL, Oberfield SE et al. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res 2002; 58:18895.
  • 13
    Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005; 365:212536.
  • 14
    White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21:24591.
  • 15
    Liszewski MK, Atkinson JP. The role of complement in autoimmunity. Immunol Ser 1991; 54:1337.
  • 16
    Lokki ML, Circolo A, Ahokas P et al. Deficiency of human complement protein C4 due to identical frameshift mutations in the C4A and C4B genes. J Immunol 1999; 162:368793.
  • 17
    Samano ET, Ribeiro LM, Gorescu RG et al. Involvement of C4 allotypes in the pathogenesis of human diseases. Clinics 2004; 59:13844.
  • 18
    Yang Y, Chung EK, Wu YL et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 2007; 80:103754.
  • 19
    Bishof NA, Welch TR, Beischel LS. C4B deficiency: a risk factor for bacteremia with encapsulated organisms. J Infect Dis 1990; 162:24850.
  • 20
    Araujo M, Sanches MP, Suzuki LA et al. Molecular analysis of CYP-21 and C4 genes in Brazilian families with the classical forms of the steroid 21-hydroxylase deficiency. Braz J Med Biol Res 1996; 29:113.
  • 21
    Paulino LC, Araujo M, Guerra-Junior G et al. Mutation distribution and CYP21/C4 locus variability in Brazilian families with the classical form of the 21-hydroxylase deficiency. Acta Paediatr 1999; 88:27583.
  • 22
    Barata RCB, Waldman EA, Moraes JC, Guibu IA, Rozov T, Takimoto S. Gastroenteritis and acute respiratory infections among children up to 5 years old in area of Southeastern Brazil, 1986–1987. I. Acute respiratory infections. Rev Saude Publica 1996; 30:53363.
  • 23
    Heffelfinger JD, Davis TE, Gebrian B, Bordeau R, Schwartz B, Dowell SF. Evaluation of children with recurrent pneumonia diagnosed by World Health Organization criteria. Pediatr Infect Dis J 2002; 21:10812.
  • 24
    Le Saux N, Pham B, Moher D. Evaluating the benefits of antimicrobial prophylaxis to prevent urinary tract infections in children: a systematic review. Can Med Assoc J 2000; 163:5239.
  • 25
    Mayer MM. Complement and complement fixation. In: KabatEA, MayerMM, eds. Experimental immuonochemistry. Springfield: Thomas, 1961:133240.
  • 26
    Joiner KA, Haiwinger A, Gelfand JA. A study of optimal reaction conditions for assay of the human alternative pathway. Am J Clin Pathol 1983; 79:6572.
  • 27
    Chrispeels J, Bank S, Rittner C et al. Sandwich enzyme-linked immunosorbent assays for the quantification of the C4 isotypes (C4A and C4B) in human plasma. J Immunol Methods 1989; 125:512.
  • 28
    Palsdottir A, Arnason A, Fossdal R et al. Gene organization of haplotypes expressing two different C4A allotypes. Hum Genet 1987; 76:2204.
  • 29
    Yu CY. Molecular genetics of the human MHC complement gene cluster. Exp Clin Immunogenet 1998; 15:21229.
  • 30
    Rupert KL, Rennebohm RM, Yu CY. An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombination between C4A and C4B genes in a patient with juvenile reumathoid arthritis. Exp Clin Immunogenet 1998; 16:8197.
  • 31
    Schneider PM, Stradmann-Bellinghausen B, Rittner C. Genetic polymorphism of the fourth component of human complement: population study and proposal for a revised nomenclature based on genomic PCR typing of Rodgers and Chido determinants. Eur J Immunogenet 1996; 3:33544.
  • 32
    Morton L, Podolsky MD. Labial fusion: a cause of recurrent urinary tract infections. Clin Pediatr (Phila) 1973; 12:3456.
  • 33
    Leung AKC, Robson WLM. Labial fusion and asymptomatic bacteriuria. Eur J Pediatr 1993; 152:2501.
  • 34
    Elder JS. Urologic disorders in infants and children. In: KliegmanR, BehrmanRE, JensonHB, StantonBF, eds. Nelson textbook of pediatrics. Philadelphia, PA: Saunders Elsevier, 2007:2255.
  • 35
    Lorini R, Gastaldi R, Traggiai C, Perucchin PP. Hashimoto's thyroiditis. Pediatr Endocrinol Rev 2003; 1 (Suppl. 2):20511.
  • 36
    Demirbilek H, Kandemir N, Gonc EN, Ozon A, Alikasifoglu A, Yordam N. Hashimoto's thyroiditis in children and adolescents: a retrospective study on clinical, epidemiological and laboratory properties of the disease. J Pediatr Endocrinol Metab 2007; 20:1199205.
  • 37
    Yang Z, Mendoza AR, Welch TR et al. Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module). A mechanism for gene deletions and disease associations. J Biol Chem 1999; 274:1214756.
  • 38
    Collier S, Sinnott PJ, Dyer PA et al. Pulsed field gel electrophoresis identifies a high degree of variability in the number of tandem 21-hydroxylase and complement C4 gene repeats in 21-hydroxylase deficiency haplotypes. EMBO J 1989; 8:1393402.
  • 39
    Weg-Remers S, Brenden M, Schwarz E et al. Major histocompatibility complex (MHC) class III genetics in two Amerindian tribes from southern Brazil: the Kaingang and the Guarani. Hum Genet 1997; 100:54856.